Gadolinium Lawyer

An elderly man in Northern California has sued various health companies after he contracted an incurable disease due to the dyes used in an MRI.
Around 215 cases of gadolinium causing nephrogenic systemic fibrosis or nephrogenic fibrosing demopathy have been reported worldwide. No cures have been found but some patients see improvement in their condition after treatments.
The FDA issued […]

[Read more →]

Gadolinium based contrast agents that are used in MRIs have been linked with Nephrogenic Systemic Fibrosis(NSF)/Nephrogenic Fibrosing Dermopathy (NFD) in patients with kidney disease. Recently, the FDA released information that suggests MRAs, a variation of MRIs, that use gadolinium based contrast agents may pose more of a risk of causing NSF than they do in traditional […]

[Read more →]

Manufacturers of Gadolinium-based contrast agents issued a Dear Healthcare Professional letter to inform healthcare professionals of the addition of a BOXED WARNING and revisions to the WARNING section of the prescribing information for Gadolinium-based contrast agents used in Magnetic Resonance Imaging (MRI).The text of the letter is as follows:Dear Healthcare Professional,
The manufacturers of gadolinium-based contrast […]

[Read more →]

Gadolinium is a chemical substance that had become quite popular in the medical community in recent years because of the benefits it provided doctors in evaluating the results of MRI scans. Basically, gadolinium serves as a contrasting agent. It is injected into the patient’s body before administering an MRI, and the result is […]

[Read more →]

On May 23, 2007, the FDA took yet another step in its constantly-growing level of regulation over gadolinium, a substance that’s been an ingredient in several popular contrasting agents used to help doctors review MRI’s and MRA’s. This represents the strongest step yet that’s been taken by the federal government.
According to the FDA, the […]

[Read more →]